- Report
- May 2025
- 267 Pages
Global
From €4371EUR$4,950USD£3,824GBP
- Report
- November 2025
- 185 Pages
Global
From €3131EUR$3,545USD£2,738GBP
€3478EUR$3,939USD£3,043GBP
- Report
- February 2025
- 180 Pages
Global
From €3974EUR$4,500USD£3,476GBP
- Report
- December 2025
- 220 Pages
Global
From €5166EUR$5,850USD£4,519GBP
- Report
- March 2025
- 175 Pages
Global
From €3965EUR$4,490USD£3,468GBP
- Report
- May 2025
- 114 Pages
Global
From €4195EUR$4,750USD£3,669GBP
- Report
- August 2025
- 147 Pages
Global
From €3488EUR$3,950USD£3,051GBP
- Report
- December 2025
- 421 Pages
Global
From €6177EUR$6,995USD£5,403GBP
- Report
- May 2025
- 100 Pages
Global
From €5254EUR$5,950USD£4,596GBP
- Report
- October 2025
- 199 Pages
Global
From €3131EUR$3,545USD£2,738GBP
€3478EUR$3,939USD£3,043GBP
- Report
- June 2025
- 182 Pages
Global
From €3974EUR$4,500USD£3,476GBP
- Report
- December 2025
- 282 Pages
Global
From €5166EUR$5,850USD£4,519GBP
- Report
- December 2025
- 174 Pages
Global
From €5166EUR$5,850USD£4,519GBP
- Report
- April 2025
- 175 Pages
Global
From €3965EUR$4,490USD£3,468GBP
- Report
- March 2025
- 200 Pages
Global
From €3965EUR$4,490USD£3,468GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1413EUR$1,600USD£1,236GBP
€1766EUR$2,000USD£1,545GBP
- Report
- May 2025
- 90 Pages
Global
From €3500EUR$4,246USD£3,169GBP
- Report
- November 2025
- 500 Pages
Global
From €3528EUR$3,995USD£3,086GBP
- Report
- November 2025
- 250 Pages
Global
From €3528EUR$3,995USD£3,086GBP
- Report
- November 2025
- 550 Pages
Global
From €3528EUR$3,995USD£3,086GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more